London healthcare firm pledges nearly £50m to 'vital' retina therapy technology -

London healthcare firm pledges nearly £50m to ‘vital’ retina therapy technology

London healthcare firm pledges nearly £50m to ‘vital’ retina therapy technology. Syncona Ltd has funded £48m of a £50.4m Series B deal to Gyroscope Therapeutics with the extra £2.4m from Cambridge Innovation Capital (CIC). Healthcare company Syncona focuses on founding, building and funding global businesses in life sciences, and retains an 80 per cent stake[…]